Low-order assemblies drive oncogenic RTK fusion signalling without condensation
In the authors' words
Receptor tyrosine kinase (RTK) fusions are a large class of oncoproteins found in ~5% of cancers. Key questions remain, however, about how RTK fusions transmit oncogenic signals, including how these largely cytoplasmic proteins activate downstream pathways that originate at the plasma membrane. Fusions are often multimeric and can form mesoscale condensates in cancer cells, and condensation has been implicated as an essential mechanism to enable signal transmission from the cytoplasm. However, whether condensates play a causal role or whether smaller ‘diffuse’ assemblies are sufficient to transduce signals, has been challenging to establish. Here we apply advanced microscopy, single-cell analysis and synthetic fusions to determine the principles by which multimerization and condensation drive signalling from cytoplasmic RTK fusions. For EML4–ALK, a prominent fusion that forms condensates, we found poor correlation between condensation and signalling and abundant EML4–ALK activity in the diffuse phase. Synthetic RTK fusions showed that cytoplasmic dimers of ALK or RET domains—and even constitutively active monomers—were sufficient to induce strong Ras–Erk signalling despite the absence of condensates, and non-condensing fusions were sufficient to transform cells in vitro and in subcutaneous tumour models. A panel of various other cancer-driving RTK fusions showed that low-order multimerization was widespread across fusions, whereas mesoscale condensation was rare and did not correlate with signalling. Our results suggest that low-order multimerization is sufficient to drive fusion phosphorylation, which is necessary and sufficient to trigger downstream oncogenic signalling. Gonzalez-Martinez, Mumford et al. show that condensate-forming fusion oncoprotein EML4–ALK can drive oncogenic Ras–Erk signalling from small multimers in the dilute phase, whereas its propensity for biomolecular condensation is dispensable.
Appeared: Sunday, November 15. Nature Cell Biology. Peer-reviewed journal.